Results 51 to 60 of about 499 (150)

Study of Urinary WT1 Positive Cells as a Biomarker for Detection of Glomerular Diseases

open access: yesRUHS Journal of Health Sciences, 2023
Introduction: Glomerular diseases form a large part of the morbidity and mortality associated with kidney diseases. Podocyte injury and loss is implicated in a number of these diseases.
Jayesh Saha , Ranjana Solanki , Madan Solanki , Utkarsh Sharma , Suman Meena , Vijaya S Devi, Poonam Arora, Gurvi Chauhan
doaj   +1 more source

Podocituria en pacientes pediátricos con enfermedad de Fabry

open access: yesNefrología, 2019
Resumen: Introducción: La enfermedad de Fabry (EF) es un trastorno hereditario causado por una deficiencia de la actividad de la enzima α-galactosidasa A, cuya transmisión está relacionada con el cromosoma X. Objetivos: Los objetivos del estudio fueron:
Miguel Liern   +8 more
doaj   +1 more source

Podocyte Injury in Cases with Newly Diagnosed Multiple Myeloma

open access: yesSaudi Journal of Kidney Diseases and Transplantation, 2021
Renal impairment is a frequent complication of multiple myeloma (MM). Our aim was to assess the expression of podocyte-associated nephrin, podocin, and vascular endothelial growth factor (VEGF) A and their relation to renal function, proteinuria, and ...
Tolga Kuzu   +4 more
doaj   +1 more source

Issue Information

open access: yes, 2022
Journal of Diabetes, Volume 14, Issue 4, Page 229-230, April 2022.
wiley   +1 more source

Case Report Copious Podocyturia without Proteinuria and with Normal Renal Function in a Young Adult with Fabry Disease [PDF]

open access: yes, 2020
The time for starting a patient with Fabry disease on enzyme replacement therapy is still a matter of debate, particularly when no overt classical clinical signs or symptoms are present.
E Zotta   +11 more
core   +3 more sources

Mass spectrometry as a novel method for detection of podocyturia in pre-eclampsia [PDF]

open access: yesNephrology Dialysis Transplantation, 2012
Podocyturia, i.e. urinary loss of viable podocytes, may serve as a diagnostic tool for pre-eclampsia and as a marker of active renal disease. The current method to detect podocyturia is technically complex, lengthy and requires a high level of expertise for interpretation.
Vesna D, Garovic   +7 more
openaire   +2 more sources

Early Renal Involvement in a Girl with Classic Fabry Disease

open access: yesCase Reports in Nephrology, Volume 2017, Issue 1, 2017., 2017
Fabry disease is an X‐linked lysosomal storage disorder resulting from the deficiency or absence of the enzyme alpha galactosidase A; this defect leads to the systemic accumulation of globotriaosylceramide and its metabolites. Organic involvement in men is well known, but in women it is controversial, mainly due to the random X‐chromosome inactivation ...
Fernando Perretta   +3 more
wiley   +1 more source

Evaluation of Tryptic Podocin Peptide in Urine Sediment Using LC-MS-MRM Method as a Potential Biomarker of Glomerular Injury in Dogs with Clinical Signs of Renal and Cardiac Disorders

open access: yesMolecules, 2019
The early asymptomatic stage of glomerular injury is a diagnostic challenge in the course of renal and extra-renal disease, e.g., heart insufficiency. It was found that podocin, a podocyte-specific protein present in the urine, may serve as a biomarker ...
Barbara Szczepankiewicz   +6 more
doaj   +1 more source

Is It Possible to Differentiate Chronic Kidney Disease and Preeclampsia by means of New and Old Biomarkers? A Prospective Study

open access: yesDisease Markers, Volume 2015, Issue 1, 2015., 2015
Objective. Chronic kidney disease (CKD) and preeclampsia (PE) may both present with hypertension and proteinuria in pregnancy. Our objective is to test the possibility of distinguishing CKD from PE by means of uteroplacental flows and maternal circulating sFlt‐1/PlGF ratio. Design. Prospective analysis. Population.
Alessandro Rolfo   +13 more
wiley   +1 more source

P1010EFFECTS OF SGLT2 INHIBITORS ON DIABETIC NEPHROPATHY: PODOCYTURIA ON FOCUS [PDF]

open access: yesNephrology Dialysis Transplantation, 2020
Abstract Background and Aims Sodium-glucose co-transporter 2 (SGLT2) inhibitors which are a class of oral anti-diabetic drugs are being used in the treatment of type 2 diabetes (T2D). Basically these drugs reduce blood glucose by blocking glucose reabsorption of primary sodium-coupled glucose ...
Mustafa Sait Gönen   +12 more
openaire   +1 more source

Home - About - Disclaimer - Privacy